TrialJAMA neurology2018

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

Vladimir Skljarevski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.